Displaying 101–125 of 11090 results for

Sort By Relevance Sort By Date
1... 3 4 5 6 7 ...444

Novartis shifts Zolgensma manipulation blame to former AveXis execs

(News)

Brian and Allan Kaspar, who were executives at AveXis last year when Novartis acquired it for $8.7 billion, were named by the embattled drugmaker as being responsible for the data mishandling.

7 of the biggest pharma bankruptcies this year

(Article)

What’s causing drug companies to go bust

Akcea’s top three execs depart

(News)

Ionis Pharmaceuticals' affiliate Akcea Therapeutics has announced the immediate departure of its chief executive officer, president and chief operating officer.

FDA places hold on Abeona late-stage study

(News)

Pharma's high hopes

(Article)

Pharma's gene therapy dreams need to be tethered with a plan

Pharma in review: trending stories 9/20/19

(News)

pharma manufacturing news in review

FDA approves expanded use for Merck HIV meds

(News)

Protestor drops 800-lb. drug spoon on J&J front steps

(News)

An activist/artist brought an 800-pound cooking spoon to Johnson and Johnson's New Jersey site as a way to protest prescription drugs' role in the opioid epidemic.

Novartis stops distribution of Zantac amidst toxin probe

(News)

Novartis’ Sandoz unit has put the brakes on its distribution of a popular heartburn medicine as regulators investigate reports that it could be contaminated.

Sanofi plans to exit Bangladesh

(News)

After 60 years of operating in Bangladesh, Sanofi is reportedly planning to leave the country, putting about 1,000 jobs in jeopardy.

Gene therapies: On the rise

(Article)

Inside the industry's struggle to produce gene therapies on a higher level

FDA grants priority review to Merck Ebola vaccine

(News)

Merck’s Biologics License Application for V920 has been accepted by the FDA as the company continues to expand investigational supply to support international Ebola outbreak response.

Sanofi partners with Happify Health for digital therapeutics

(News)

The two will be developing and studying an app to help manage and improve psychological outcomes in people with multiple sclerosis.

Making the case for Indian generic drug manufacturing

(Article)

In response to the growing regulatory environment, pharmaceutical companies in India continue to strengthen their processes, while improving automation, operating procedures and quality management systems.

AstraZeneca diabetes drug gets fast track designation for heart indication

(News)

The prospects for an AstraZeneca diabetes drug receiving a major new indication are looking even brighter.

Possible carcinogen found in popular heartburn meds

(News)

Regulators in the U.S. and EU are taking a closer look at medication containing ranitidine after the presence of a probable carcinogen was found in several samples.

Lundbeck buys Alder, eyeing migraine drug

(News)

Denmark’s Lundbeck has agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to profit from a potential blockbuster migraine drug.

Purdue Pharma files for bankruptcy as part of opioid settlement

(News)

Purdue Pharma filed for Chapter 11 bankruptcy in New York as part of its framework for settling litigation with states and local governments in a massive opioid lawsuit.

Pharma in review: trending stories 9/13/19

(News)

pharma manufacturing news in review

Bayer reduces management board amid ongoing company shake-up

(News)

Bayer’s quest to reduce its workforce has traveled all the way up into the company’s highest ranks.

Sanofi forks over $260M to end diabetes partnership

(News)

Sanofi will pay Lexicon Pharmaceuticals $260 million to terminate a partnership related to the development of a diabetes drug.

Vertex to sell cystic fibrosis drugs in Scotland

(News)

Amid Vertex’s continuing drug pricing battle with British regulators, the drugmaker has signed a deal to make two of its cystic fibrosis drugs available in Scotland.

CAR-T may treat heart disease, says study

(News)

A first-of-its-kind study by researchers at Penn Medicine found that CAR-T cell therapy may be a viable treatment option for heart disease.

Data analytics moves beyond Dilbert

(Article)

Why pharma manufacturers shouldn’t get stuck in a comic

Sort By Relevance Sort By Date
1... 3 4 5 6 7 ...444